Skip to main content
. 2013 Feb 13;7:31–39. doi: 10.4137/CMO.S10839

Figure 2.

Figure 2.

Hematological toxicities according to genotype (C/C, C/T, or T/T) in patients receiving AMR at a dose of 40 mg/m2. Percentage decrease changes in WBC (A), neutropenia (B), hemoglobin (C), and platelet counts (D) were related to NQO1 C609T genotypes (A) P = 0.013; (B) P = 0.105; (C) P = 0.027; (D) P = 0.0005, respectively.

Note: **P < 0.05.